UniProt ID | SE1L1_HUMAN | |
---|---|---|
UniProt AC | Q9UBV2 | |
Protein Name | Protein sel-1 homolog 1 | |
Gene Name | SEL1L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 794 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type I membrane protein . |
|
Protein Description | Plays a role in the endoplasmic reticulum quality control (ERQC) system also called ER-associated degradation (ERAD) involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins. [PubMed: 16186509 Enhances SYVN1 stability. Plays a role in LPL maturation and secretion. Required for normal differentiation of the pancreas epithelium, and for normal exocrine function and survival of pancreatic cells. May play a role in Notch signaling.] | |
Protein Sequence | MRVRIGLTLLLCAVLLSLASASSDEEGSQDESLDSKTTLTSDESVKDHTTAGRVVAGQIFLDSEESELESSIQEEEDSLKSQEGESVTEDISFLESPNPENKDYEEPKKVRKPALTAIEGTAHGEPCHFPFLFLDKEYDECTSDGREDGRLWCATTYDYKADEKWGFCETEEEAAKRRQMQEAEMMYQTGMKILNGSNKKSQKREAYRYLQKAASMNHTKALERVSYALLFGDYLPQNIQAAREMFEKLTEEGSPKGQTALGFLYASGLGVNSSQAKALVYYTFGALGGNLIAHMVLGYRYWAGIGVLQSCESALTHYRLVANHVASDISLTGGSVVQRIRLPDEVENPGMNSGMLEEDLIQYYQFLAEKGDVQAQVGLGQLHLHGGRGVEQNHQRAFDYFNLAANAGNSHAMAFLGKMYSEGSDIVPQSNETALHYFKKAADMGNPVGQSGLGMAYLYGRGVQVNYDLALKYFQKAAEQGWVDGQLQLGSMYYNGIGVKRDYKQALKYFNLASQGGHILAFYNLAQMHASGTGVMRSCHTAVELFKNVCERGRWSERLMTAYNSYKDGDYNAAVIQYLLLAEQGYEVAQSNAAFILDQREASIVGENETYPRALLHWNRAASQGYTVARIKLGDYHFYGFGTDVDYETAFIHYRLASEQQHSAQAMFNLGYMHEKGLGIKQDIHLAKRFYDMAAEASPDAQVPVFLALCKLGVVYFLQYIRETNIRDMFTQLDMDQLLGPEWDLYLMTIIALLLGTVIAYRQRQHQDMPAPRPPGPRPAPPQQEGPPEQQPPQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MRVRIGLTLLLCAVL CCHHHHHHHHHHHHH | 15.33 | 22210691 | |
28 | Phosphorylation | ASSDEEGSQDESLDS CCCCCCCCCCCCCCC | 37.42 | 22210691 | |
32 | Phosphorylation | EEGSQDESLDSKTTL CCCCCCCCCCCCCEE | 45.85 | - | |
37 | O-linked_Glycosylation | DESLDSKTTLTSDES CCCCCCCCEECCCHH | 30.87 | 55835871 | |
37 | Phosphorylation | DESLDSKTTLTSDES CCCCCCCCEECCCHH | 30.87 | 26699800 | |
38 | O-linked_Glycosylation | ESLDSKTTLTSDESV CCCCCCCEECCCHHH | 31.60 | 55835875 | |
38 | Phosphorylation | ESLDSKTTLTSDESV CCCCCCCEECCCHHH | 31.60 | 26699800 | |
40 | Phosphorylation | LDSKTTLTSDESVKD CCCCCEECCCHHHCC | 31.85 | 26657352 | |
40 | O-linked_Glycosylation | LDSKTTLTSDESVKD CCCCCEECCCHHHCC | 31.85 | OGP | |
41 | Phosphorylation | DSKTTLTSDESVKDH CCCCEECCCHHHCCC | 42.36 | 29255136 | |
41 | O-linked_Glycosylation | DSKTTLTSDESVKDH CCCCEECCCHHHCCC | 42.36 | 69003355 | |
44 | Phosphorylation | TTLTSDESVKDHTTA CEECCCHHHCCCCCC | 39.18 | 29255136 | |
44 | O-linked_Glycosylation | TTLTSDESVKDHTTA CEECCCHHHCCCCCC | 39.18 | 55835883 | |
46 | Ubiquitination | LTSDESVKDHTTAGR ECCCHHHCCCCCCCE | 53.74 | - | |
49 | Phosphorylation | DESVKDHTTAGRVVA CHHHCCCCCCCEEEE | 28.60 | 23312004 | |
49 | O-linked_Glycosylation | DESVKDHTTAGRVVA CHHHCCCCCCCEEEE | 28.60 | 55835889 | |
50 | Phosphorylation | ESVKDHTTAGRVVAG HHHCCCCCCCEEEEE | 24.56 | 23312004 | |
50 | O-linked_Glycosylation | ESVKDHTTAGRVVAG HHHCCCCCCCEEEEE | 24.56 | 55835895 | |
63 | Phosphorylation | AGQIFLDSEESELES EEEEEECCCHHHHHH | 45.47 | 28192239 | |
66 | Phosphorylation | IFLDSEESELESSIQ EEECCCHHHHHHHHH | 43.35 | 20639409 | |
70 | Phosphorylation | SEESELESSIQEEED CCHHHHHHHHHHHHH | 45.42 | 20639409 | |
71 | Phosphorylation | EESELESSIQEEEDS CHHHHHHHHHHHHHH | 20.93 | 20639409 | |
78 | Phosphorylation | SIQEEEDSLKSQEGE HHHHHHHHHHHCCCC | 40.76 | 20639409 | |
81 | Phosphorylation | EEEDSLKSQEGESVT HHHHHHHHCCCCCHH | 38.46 | 29759185 | |
88 | O-linked_Glycosylation | SQEGESVTEDISFLE HCCCCCHHHHHHHHC | 36.90 | OGP | |
96 | O-linked_Glycosylation | EDISFLESPNPENKD HHHHHHCCCCCCCCC | 31.93 | OGP | |
160 | Ubiquitination | CATTYDYKADEKWGF EEEECEECCCCCCCC | 46.60 | - | |
176 | Ubiquitination | ETEEEAAKRRQMQEA CCHHHHHHHHHHHHH | 55.98 | - | |
189 | Phosphorylation | EAEMMYQTGMKILNG HHHHHHHHHHHHHCC | 23.04 | 28258704 | |
195 | N-linked_Glycosylation | QTGMKILNGSNKKSQ HHHHHHHCCCCCHHH | 56.15 | UniProtKB CARBOHYD | |
197 | Phosphorylation | GMKILNGSNKKSQKR HHHHHCCCCCHHHHH | 44.39 | 28258704 | |
212 | Ubiquitination | EAYRYLQKAASMNHT HHHHHHHHHHHCCCH | 43.24 | - | |
217 | N-linked_Glycosylation | LQKAASMNHTKALER HHHHHHCCCHHHHHH | 36.86 | UniProtKB CARBOHYD | |
248 | Ubiquitination | AAREMFEKLTEEGSP HHHHHHHHHHHCCCC | 49.82 | - | |
272 | N-linked_Glycosylation | YASGLGVNSSQAKAL HHCCCCCCHHHHHHH | 33.86 | 12754519 | |
272 | N-linked_Glycosylation | YASGLGVNSSQAKAL HHCCCCCCHHHHHHH | 33.86 | 12754519 | |
431 | N-linked_Glycosylation | SDIVPQSNETALHYF CCCCCCCCHHHHHHH | 45.45 | 19159218 | |
440 | Ubiquitination | TALHYFKKAADMGNP HHHHHHHHHHHCCCC | 38.62 | - | |
457 | Phosphorylation | QSGLGMAYLYGRGVQ CCCCCHHHHHCCCEE | 7.49 | - | |
472 | Ubiquitination | VNYDLALKYFQKAAE ECHHHHHHHHHHHHH | 38.11 | - | |
503 | Phosphorylation | GIGVKRDYKQALKYF CCCCCCCHHHHHHHH | 14.72 | 29083192 | |
504 | Ubiquitination | IGVKRDYKQALKYFN CCCCCCHHHHHHHHC | 33.12 | - | |
571 | Phosphorylation | NSYKDGDYNAAVIQY HHCCCCCCHHHHHHH | 16.54 | 26074081 | |
578 | Phosphorylation | YNAAVIQYLLLAEQG CHHHHHHHHHHHHCC | 6.54 | 26074081 | |
586 | Phosphorylation | LLLAEQGYEVAQSNA HHHHHCCHHHHHHCC | 13.61 | 26074081 | |
591 | Phosphorylation | QGYEVAQSNAAFILD CCHHHHHHCCEEEEC | 20.78 | 26074081 | |
603 | Phosphorylation | ILDQREASIVGENET EECCHHHCCCCCCCC | 17.04 | 26074081 | |
608 | N-linked_Glycosylation | EASIVGENETYPRAL HHCCCCCCCCCCHHH | 40.77 | 19159218 | |
610 | O-linked_Glycosylation | SIVGENETYPRALLH CCCCCCCCCCHHHHH | 50.86 | 30059200 | |
632 | Ubiquitination | GYTVARIKLGDYHFY CCEEEEEEECCEEEE | 40.64 | - | |
639 | Phosphorylation | KLGDYHFYGFGTDVD EECCEEEECCCCCCC | 9.76 | 30387612 | |
663 | Phosphorylation | LASEQQHSAQAMFNL HHHCCHHHHHHHHHH | 20.10 | 30387612 | |
676 | Ubiquitination | NLGYMHEKGLGIKQD HHHHHHHCCCCCCHH | 44.77 | - | |
681 | Ubiquitination | HEKGLGIKQDIHLAK HHCCCCCCHHHHHHH | 39.87 | - | |
688 | Ubiquitination | KQDIHLAKRFYDMAA CHHHHHHHHHHHHHH | 49.77 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SE1L1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SE1L1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SE1L1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-431 AND ASN-608, AND MASSSPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-272. |